Clinical Trial

Effectiveness of Breastfeeding Arm Sling and Biological Feeding Position in Primiparous Womenl

Study acronym: EBASBFP
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 27, 2025 (before its estimated November 28, 2025 completion). Its status may not reflect the trial's current state.
Summary
Abstract The World Health Organization (WHO) recommends that babies be fed exclusively with breast milk for the first six months after birth (World Health Organization, 2020). However, for women who are breastfeeding for the first time (primiparas), the breastfeeding process often presents both physical and psychological challenges. In recent years, technological and ergonomic solutions have been developed to support the breastfeeding process, and a new tool called a 'breastfeeding arm sling' is planned to be developed. This arm sling aims to support the mother's arm, allowing the baby to be positioned more stably and thus making the breastfeeding process more comfortable . On the other hand, the biological feeding position (laid-back breastfeeding) is an effective method that uses the effects of gravity to activate the baby's natural reflexes and allows the mother to breastfeed in a comfortable position . This study is a randomised controlled experimental study aimed at comparing the effects of the newly developed Breastfeeding Arm Support and the biological feeding position on breastfeeding in primiparous women. The research will be conducted with primiparous women who gave birth between September and December 2025 at the Women's Delivery Services 1 and 2 of Gaziantep Abdulkadir Yüksel State Hospital. Data will be collected through face-to-face interviews and questionnaire forms in the form of pre-tests and post-tests. The study includes two groups: 1. Group receiving the Breastfeeding Arm Support group (n = 44) 2. Group receiving the Biological Feeding Position (n = 44) Post-intervention post-tests will be administered to both groups, and the results will be compared.
Trial Details
NCT Number NCT07144358
Lead Sponsor Hatice Gul OZTAS
Conditions Primiparous Women
Enrollment 88 participants
Start Date 2025-09-20
Primary Completion 2025-11-28 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-27